Evidence map›Paper›PMID 37713157›Full record

ReviewPurinergic signalling2024

P2X7 receptors and pannexin1 hemichannels shape presynaptic transmission.

Nathalia Vitureira, Alberto Rafael, Verónica Abudara

Abstract readReview
In one paragraph

Review in Purinergic signalling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nathalia VitureiraDepartamento de Fisiología, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay. nvitureira@fmed.edu.uy.ORCID 0000-0003-1196-4094
Alberto RafaelDepartamento de Fisiología, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Verónica AbudaraDepartamento de Fisiología, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay. abudara@fmed.edu.uy.ORCID 0000-0003-0703-306X

Funding

Comisión Sectorial de Investigación Científica 22320200200227UDComisión Sectorial de Investigación Científica 22520220100095UDComisión Sectorial de Investigación Científica 22520220100243UD
6 · The paper itself

Abstract

Over the last decades, since the discovery of ATP as a transmitter, accumulating evidence has been reported about the role of this nucleotide and purinergic receptors, in particular P2X7 receptors, in the modulation of synaptic strength and plasticity. Purinergic signaling has emerged as a crucial player in orchestrating the molecular interaction between the components of the tripartite synapse, and much progress has been made in how this neuron-glia interaction impacts neuronal physiology under basal and pathological conditions. On the other hand, pannexin1 hemichannels, which are functionally linked to P2X7 receptors, have appeared more recently as important modulators of excitatory synaptic function and plasticity under diverse contexts. In this review, we will discuss the contribution of ATP, P2X7 receptors, and pannexin hemichannels to the modulation of presynaptic strength and its impact on motor function, sensory processing, synaptic plasticity, and neuroglial communication, with special focus on the P2X7 receptor/pannexin hemichannel interplay. We also address major hypotheses about the role of this interaction in physiological and pathological circumstances.

Indexed as

ConnexinsNerve Tissue ProteinsReceptors, Purinergic P2X7Synaptic TransmissionAdenosine TriphosphateAnimalsHumansNeuronal PlasticityPresynaptic TerminalsAdenosine TriphosphateConnexinsNerve Tissue ProteinsPANX1 protein, humanReceptors, Purinergic P2X7ATPP2X7RsPanx1HCsPresynaptic functionTripartite synapse

Identifiers

PMID37713157
PMCPMC11189373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.